Uncategorized

Noticias de la actualidad científica y tecnológica del 14 de abril de 2023.     …

Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.

Zucara Therapeutics Inc., today announced that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s Investigational New Drug (“IND”) application for ZT-01 for the prevention of night-time (nocturnal) hypoglycemia in patients with Type 1 Diabetes (“T1D”).

Palatin Technologies today announced preliminary fiscal third quarter ended March 31, 2023 Vyleesi® product revenue results.

Annovis Bio, Inc. today announced that patient recruitment for the Company’s Phase 2/3 study of buntanetap for the treatment of moderate Alzheimer’s disease (AD) remains consistent with its planned development program.

BioArctic AB will publish the company’s first quarter report for January – March 2023 on Thursday, April 27, 2023, at 08:00 a.m. CET.

Hay un agujero negro que, pese a su enorme masa de 20 millones de veces la de nuestro Sol, avanza por el espacio intergaláctico muchísimo más rápido que la más veloz de nuestras naves espaciales. A esa velocidad, este astro tan masivo podría viajar de la Tie …

Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the Stifel 2023 Virtual Targeted Oncology Days on Wednesday, April 26, 2023, at 1:30 p.m. ET.

AlzeCure Pharma AB announced that an abstract on ACD440, the leading non-opioid drug candidate in the Painless platform, has been accepted for presentation at the annual international pain conference EFIC, European Pain Federation, which this year is being held in Budapest, Hungary, on September 20-22.

Lytix Biopharma AS, a clinical stage immuno-oncology company, announces the election of a new Chairman of the Board at ‘s General Assembly.